Cryoablation is a technique that uses extreme cold for denaturing the diseased tissues in the human body. In cryoablation therapy, liquid nitrogen or argon gas is passed to the site of treatment using a probe, which creates intense cold that freezes the internal tumors. The procedure is often carried out multiple times till the affected tissue is totally destroyed. The technique yields high effectiveness for treatment of various tumors such as that in the bones, kidneys, breasts, lungs, and liver, and can also be used to treat certain skin conditions. The probe is guided using MRI and ultrasound, which locates the exact position of the affected tissue that proves the specificity of the therapy. The specificity and the effectiveness of the therapy is expected to favor the for cryoablation devices market in the near future.
Rise in incidence rate for various types of cancer is expected to fuel the growth for cryoablation therapy
Cryoablation is mainly used for primary treatment of cancer in order to destroy tumor cells. In 2012, there were approximately 14 million new cases and 8.2 million cancer-related deaths. According to the WHO, the number of new cancer cases is expected to increase by 70% by 2030. Furthermore, in 2015, there were around 9 million deaths attributed to various types of cancers. The five leading cause of cancers includes the change in lifestyle and unhealthy eating habits along with increasing consumption of tobacco and alcohol. This inadvertently creates a highly conducive environment for growth for cryoablation devices market. Furthermore, Cryoablation therapy is also useful in treating cardiac arrhythmias, by restoring the heart’s electrical impulses by freezing the cardiac tissue or pathways that interfere with the normal cardiac impulse conduction, which in turn is expected to support the cryoablation devices industry. According to World Heart Federation, the prevalence of atrial fibrillation grows with advance in age to a prevalence of around 9% for ages 80–89. This states that the number of individuals in this age group are more prone to arrhythmias and the region having more geriatric population is expected to contribute more in cryoablation therapy market in terms of value in the near future.
On the basis of device type, application, and end users the global cryoablation devices market is segmented as follows:
Cryoablation devices in the market: Freezor Cardiac CryoAblation Catheter (Medtronic), CryoCor Cryoablation System (CryoCor Inc.), Freezor Xtra Surgical Cardiac Cryoablation Device (Medtronic), cryoFORM (AtriCure, Inc.), Visual-ICE Cryoablation System (Galil Medical Inc.), and Freezor Max Surgical Cardiac Cryoablation Device (Medtronic).
Emerging economies to emerge as growth engine for cryoblation devices market
Developed economies such as the U.S., Canada, U.K., Germany, and Japan experience high adoption rate of cryoablation devices. This is mainly attributed to high incidence of cardiac disorders such as cardiac arrhythmia, atrial fibrillation, and atrial flutter and increasing geriatric population in these regions, according to American Heart Association, accounting for 17.3 million deaths per year. This number is projected to rise to around 23.6 million by 2030. In 2011, in U.S. around 790,000 people died from heart disease, stroke and other cardiovascular diseases. The above mentioned statistics are projected to support the cryoablation devices market. Moreover, favorable reimbursement policies, and highly advanced healthcare infrastructure in these countries are also contributing to growth of the market for cryoablation devices. For instance, most of the patients suffering from cardiovascular age are of Medicare age, facilities are reimbursed on a fixed inpatient payment guided and governed by MS-DRG system effective from October 2008, which provides efficient care to maintain financial viability. However, emerging economies such as India, Brazil, and Mexico are expected to be key growth regions that would propel cryoablation devices market growth over the following decade. Emergence of various minimally invasive therapies further creates a high growth application area for cryoablation devices. However, complications such as heart stroke and narrowing of the pulmonary veins and high costs associated with these devices is inhibiting market growth to a certain extent.
Technological advancements increasing scope of application of cryoablation devices
AtriCure Inc. launched the cryoFORM cryoablation probe in 2015 that offers high probe flexibility and hence can easily be adapted to a large variety of surgical ablation procedures. CryoFORM is mainly used for minimal invasive surgeries in cardiac surgeries, including mitral and aortic valve repair. Various studies are underway regarding the use of cryoablation use in various other health related problems such as nonsurgical treatment option for patients with early-stage disease. According to HemOnc Today, in 2017, it was stated that Cryoablation may be viable alternative to surgery for some early breast cancers and an effective technique for noncancerous fibroadenomas of the breast, as well as liver, lung and kidney cancers.
Key Market Players
The global cryoablation devices market is highly fragmented owing to the participation of many global and local players, with various mid-to-large-sized companies involved in research and development of cryoablation devices.. Companies mainly focus on development products to cater to various applications and inorganic growth strategies in order to differentiate their product offerings and enhance their presence in the market. Major players involved in the cryoablation devices industry are Galil Medical Inc., Medtronic Inc., Cooper Surgical Inc., Boston Scientific Corporation, AtriCure, Inc., Smith & Nephew plc., Varian Medical Systems, Inc., Integra LifeSciences Holdings Corporation, Terumo Corporation, and Johnson & Johnson Pvt. Ltd..
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.